JP2021522330A5 - - Google Patents
Info
- Publication number
- JP2021522330A5 JP2021522330A5 JP2021506619A JP2021506619A JP2021522330A5 JP 2021522330 A5 JP2021522330 A5 JP 2021522330A5 JP 2021506619 A JP2021506619 A JP 2021506619A JP 2021506619 A JP2021506619 A JP 2021506619A JP 2021522330 A5 JP2021522330 A5 JP 2021522330A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- cocrystal
- following
- measured
- parameters listed
- Prior art date
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024030150A JP7721712B2 (ja) | 2018-04-18 | 2024-02-29 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
| JP2025127411A JP2025166011A (ja) | 2018-04-18 | 2025-07-30 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862659226P | 2018-04-18 | 2018-04-18 | |
| US62/659,226 | 2018-04-18 | ||
| PCT/US2019/027880 WO2019204446A1 (en) | 2018-04-18 | 2019-04-17 | Gabaa positive allosteric modulator compounds, methods of making, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024030150A Division JP7721712B2 (ja) | 2018-04-18 | 2024-02-29 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021522330A JP2021522330A (ja) | 2021-08-30 |
| JPWO2019204446A5 JPWO2019204446A5 (https=) | 2022-04-25 |
| JP2021522330A5 true JP2021522330A5 (https=) | 2022-04-25 |
| JP7449272B2 JP7449272B2 (ja) | 2024-03-13 |
Family
ID=68239798
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506619A Active JP7449272B2 (ja) | 2018-04-18 | 2019-04-17 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
| JP2024030150A Active JP7721712B2 (ja) | 2018-04-18 | 2024-02-29 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
| JP2025127411A Pending JP2025166011A (ja) | 2018-04-18 | 2025-07-30 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024030150A Active JP7721712B2 (ja) | 2018-04-18 | 2024-02-29 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
| JP2025127411A Pending JP2025166011A (ja) | 2018-04-18 | 2025-07-30 | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US11542263B2 (https=) |
| EP (1) | EP3781566A4 (https=) |
| JP (3) | JP7449272B2 (https=) |
| KR (2) | KR102799156B1 (https=) |
| CN (2) | CN112384513A (https=) |
| AU (2) | AU2019255282B2 (https=) |
| BR (1) | BR112020021104A2 (https=) |
| CA (1) | CA3096890A1 (https=) |
| CL (1) | CL2020002663A1 (https=) |
| IL (1) | IL278067A (https=) |
| MX (2) | MX2020010878A (https=) |
| SG (1) | SG11202010220QA (https=) |
| TW (1) | TW202012402A (https=) |
| WO (1) | WO2019204446A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7449272B2 (ja) * | 2018-04-18 | 2024-03-13 | ニューロサイクル・セラピューティクス・インコーポレイテッド | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
| SG11202109526PA (en) * | 2019-03-18 | 2021-10-28 | Neurocycle Therapeutics Inc | Use of gabaa receptor modulators for treatment of pain |
| JP2022553718A (ja) * | 2019-10-22 | 2022-12-26 | ニューロサイクル・セラピューティクス・インコーポレイテッド | Ｇａｂａａ陽性アロステリック調節因子化合物、作成方法、およびその使用 |
| KR20220087507A (ko) * | 2019-10-23 | 2022-06-24 | 뉴로사이클 테라퓨틱스, 인크. | Gabaa 수용체 조절제를 사용한 간질 병태의 치료 |
| US12233070B2 (en) * | 2020-06-30 | 2025-02-25 | University Of Mississippi Medical Center | Methods for treating benzodiazepine misuse/use disorder |
| AU2023356939A1 (en) * | 2022-10-04 | 2025-04-10 | Engrail Therapeutics, Inc. | Gaba a receptor modulators and uses thereof |
| WO2025175214A1 (en) * | 2024-02-16 | 2025-08-21 | Engrail Therapeutics, Inc. | Methods of treating generalized anxiety disorder |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2802343C2 (de) | 1978-01-20 | 1982-04-22 | Peter Prof. Dr.-Ing. Friderichs | Latentwärmespeicher-Behälter |
| GB9813576D0 (en) * | 1998-06-24 | 1998-08-19 | Merck Sharp & Dohme | Therapeutic agents |
| CA2427779A1 (en) * | 2000-11-10 | 2002-05-16 | Merck Sharp & Dohme Limited | Imidazo-triazine derivatives as ligands for gaba receptors |
| GB0117277D0 (en) | 2001-07-16 | 2001-09-05 | Merck Sharp & Dohme | Therapeutic agents |
| TWI248936B (en) | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| JP2004170323A (ja) | 2002-11-22 | 2004-06-17 | Sumitomo Pharmaceut Co Ltd | 皮膚疾患治療剤のスクリーニング方法 |
| WO2009021957A2 (en) | 2007-08-14 | 2009-02-19 | Novartis Ag | Tricyclic heterocyclic compounds as gaba a modulators |
| WO2009143211A2 (en) | 2008-05-21 | 2009-11-26 | Incyte Corporation | Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| US20110082147A1 (en) | 2009-07-24 | 2011-04-07 | Concert Pharmaceuticals, Inc. | Substituted imidazotriazines |
| MX362181B (es) | 2013-02-19 | 2019-01-08 | Ono Pharmaceutical Co | Compuesto inhibidor de cinasa del receptor de tropomiosina (trk). |
| WO2015072853A1 (en) | 2013-11-13 | 2015-05-21 | Rjg Developments B.V. | Treatment of herpes virus infection outbreaks |
| SG11201806393QA (en) * | 2016-01-27 | 2018-08-30 | Univ Zuerich | Use of gabaa receptor modulators for treatment of itch |
| JP7449272B2 (ja) * | 2018-04-18 | 2024-03-13 | ニューロサイクル・セラピューティクス・インコーポレイテッド | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 |
-
2019
- 2019-04-17 JP JP2021506619A patent/JP7449272B2/ja active Active
- 2019-04-17 TW TW108113441A patent/TW202012402A/zh unknown
- 2019-04-17 CN CN201980041321.7A patent/CN112384513A/zh active Pending
- 2019-04-17 KR KR1020207033073A patent/KR102799156B1/ko active Active
- 2019-04-17 BR BR112020021104-4A patent/BR112020021104A2/pt unknown
- 2019-04-17 WO PCT/US2019/027880 patent/WO2019204446A1/en not_active Ceased
- 2019-04-17 MX MX2020010878A patent/MX2020010878A/es unknown
- 2019-04-17 CA CA3096890A patent/CA3096890A1/en active Pending
- 2019-04-17 KR KR1020257012376A patent/KR20250057112A/ko active Pending
- 2019-04-17 EP EP19788410.9A patent/EP3781566A4/en active Pending
- 2019-04-17 SG SG11202010220QA patent/SG11202010220QA/en unknown
- 2019-04-17 AU AU2019255282A patent/AU2019255282B2/en active Active
- 2019-04-17 CN CN202511219750.2A patent/CN121135719A/zh active Pending
-
2020
- 2020-10-14 MX MX2024004400A patent/MX2024004400A/es unknown
- 2020-10-15 IL IL278067A patent/IL278067A/en unknown
- 2020-10-15 CL CL2020002663A patent/CL2020002663A1/es unknown
- 2020-10-16 US US17/072,282 patent/US11542263B2/en active Active
-
2022
- 2022-12-28 US US18/089,661 patent/US12134619B2/en active Active
-
2024
- 2024-02-29 JP JP2024030150A patent/JP7721712B2/ja active Active
- 2024-10-02 US US18/904,228 patent/US20250034155A1/en active Pending
- 2024-11-07 AU AU2024259803A patent/AU2024259803A1/en active Pending
-
2025
- 2025-07-30 JP JP2025127411A patent/JP2025166011A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522330A5 (https=) | ||
| JP7095106B2 (ja) | オキサジアゾール一過性受容器電位チャネル阻害剤 | |
| AU2021389180A9 (en) | Heteroaryl carboxamide compound | |
| JP7449272B2 (ja) | Ｇａｂａａ陽性アロステリックモジュレーター化合物、その作製の方法および使用 | |
| DE19629652A1 (de) | 4-Amino-pyrimidin-Derivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung | |
| CN1227233C (zh) | 纯晶形的5－氯－3－(4－甲磺酰基苯基)－6′－甲基－[2,3′]联吡啶及其合成方法 | |
| BG62169B1 (bg) | 3-(5-тетразолил-бензил)амино-пиперидинови производни, методи за получаването им и фармацевтични състави с тях, използвани κακτο при метод за лечение, така и за производство на лекарства с приложе- ние при лечение на състояния, в които тахикинините са посредници | |
| JP2014040426A (ja) | ［５−（４，６−ジメチル−１ｈ−ベンゾイミダゾール−２−イル）−４−メチル−ピリミジン−２−イル］−［３−（１−メチル−ピペリジン−４−イル）−プロピル］−アミンの結晶性ヘミタートレート | |
| KR101148580B1 (ko) | Ｍｇｌｕｒ5 수용체 길항제의 다형체 | |
| TWI772424B (zh) | 一種苯并呋喃類衍生物游離鹼的晶型及製備方法 | |
| JP5781527B2 (ja) | ４−置換−２−フェノキシ−フェニルアミンデルオピオイド受容体調節因子 | |
| TW201738233A (zh) | 吲唑之合成 | |
| JP2016511262A (ja) | 置換二環式ジヒドロピリミジノン及び好中球エラスターゼ活性の阻害薬としてのそれらの使用 | |
| JP2015143255A (ja) | 疼痛症候群および他の障害の治療法 | |
| GB2378702A (en) | Novel corticotropin-releasing factor compounds | |
| JP2008512438A (ja) | 療法用ジフェニルエーテル系リガンド | |
| JPWO2019204446A5 (https=) | ||
| WO2021191837A1 (en) | 1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa α5 receptor modulators | |
| WO2025067468A1 (en) | Cbl-b inhibitors and methods of uses thereof | |
| RU2020134403A (ru) | Gabaa-положительные аллостерические соединения-модуляторы, способы их получения и применения | |
| CA2452009A1 (en) | Chemical compounds | |
| CN101622257A (zh) | N-{2-氟-5-[3-(噻吩-2-羰基)-吡唑并[1,5-a]嘧啶-7-基]-苯基}-N-甲基-乙酰胺的多晶型B | |
| JP2021512893A5 (https=) | ||
| WO2025155830A1 (en) | Crystalline forms of 3-(7-chloro-1h-indazol-5-yl)-2,5-bis(trifluoromethyl)-3h-imidazo[4,5-b]pyridine and their use in the treatment of epilepsy | |
| DE19608631A1 (de) | 4-Amino-pyrimidin-Derivate, diese Verbindungen enthaltende Arnzeimittel, deren Verwendung und Verfahren zu ihrer Herstellung |